US2013317255A1PendingUtilityA1

Process for the preparation of rotigotine

49
Assignee: FIDIA FARMACEUTICIPriority: Sep 26, 2008Filed: Jul 23, 2013Published: Nov 28, 2013
Est. expirySep 26, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61P 43/00C07D 333/08C07D 333/20C07C 213/08C07C 211/38C07C 2602/10C07C 215/64A61P 25/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for the preparation of Rotigotine (1) and of pharmaceutically acceptable salts thereof, which comprises the reductive amination of an amine of formula 6 with the 2-thienylacetic acid-sodium boron hydride complex and which makes use of hydrobromide 5 as an intermediate The process is advantageous from the industrial point of view in that it allows to obtain Rotigotine with high enantiomeric purity starting from optically active 5,6,7,8-tetrahydro-6-(S)—N-propylamino-1-methoxy-naphthalene (2), avoiding the use of dangerous reactives, the need for difficult chromatographic separation or the formation of by-products. Furthermore, two novel crystalline forms are disclosed.

Claims

exact text as granted — not AI-modified
1 . 2-N-Propyl-5-hydroxy tetraline hydrobromide 5

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.